COVID-19 transmission: a rapid systematic review of current knowledge

Objectives The objective of this study was to identify the potential and definite sources of transmission of coronavirus disease 2019 (COVID-19). Methods Due to time constraints and the acute nature of the pandemic, we searched only PubMed/MEDLINE from inception until January 28, 2021. We analyzed t...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Panagiotis Mourmouris, Lazaros Tzelves, Christiana Roidi, Anastasia Fotsali
Formato: article
Lenguaje:EN
Publicado: Korea Centers for Disease Control & Prevention 2021
Materias:
Acceso en línea:https://doaj.org/article/26897f93ca234727a2dd6c862e31b31b
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
Descripción
Sumario:Objectives The objective of this study was to identify the potential and definite sources of transmission of coronavirus disease 2019 (COVID-19). Methods Due to time constraints and the acute nature of the pandemic, we searched only PubMed/MEDLINE from inception until January 28, 2021. We analyzed the level of evidence and risk of bias in each category and made suggestions accordingly. Results The virus was traced from its potential origin via possible ways of transmission to the last host. Symptomatic human-to-human transmission remains the driver of the epidemic, but asymptomatic transmission can potentially contribute in a substantial manner. Feces and fomites have both been found to contain viable virus; even though transmission through these routes has not been documented, their contribution cannot be ruled out. Finally, transmission from pregnant women to their children has been found to be low (up to 3%). Conclusion Even though robust outcomes cannot be easily assessed, medical personnel must maintain awareness of the main routes of transmission (via droplets and aerosols from even asymptomatic patients). This is the first attempt to systematically review the existing knowledge to produce a paper with a potentially significant clinical impact.